Safe Supply Streaming Co Ltd. Releases Strategic Corporate Update as Commercial Traction, Government Engagement, and Platform Expansion Accelerate

Executive Summary

• Safe Supply Streaming Co Ltd. announced a comprehensive corporate update highlighting progress toward commercial execution, government engagement, and a planned corporate name and ticker symbol change.
• The company completed its first sale of an NIRLAB drug‑analysis device under an exclusive Canadian distribution agreement and reported an upsized financing that strengthens its balance sheet for near‑term commercialization.
• Ongoing stakeholder demonstrations, preparation for safety‑strip product launches in North America, and continued development of GLP‑1 health initiatives were outlined as part of the firm’s growth strategy.

Key Details

• Brand Evolution: Plans to change corporate name and ticker symbol pending regulatory and exchange approvals to better reflect a multi‑vertical medical‑technology platform.
• NIRLAB Sale: Completed sale of one NIRLAB SA drug analysis device to Far North Resources Inc., marking the first transaction under the exclusive Canadian distribution agreement with NIRLAB.
• Stakeholder Demonstrations: Conducted live demonstrations of the NIRLAB device for federal, provincial, municipal and Indigenous agencies in Ottawa, emphasizing applications for public safety and rapid response.
• Safety Strips Commercialization: Through subsidiaries Safety Strips Tech Corp. and Drug Lab 118 Ltd., preparing to launch fentanyl and drink‑spiking detection strips in U.S. and Canadian markets via government procurement, institutional partners, and direct‑to‑consumer channels; timing and distribution pathways under assessment.
• GLP‑1 Health & Wellness Initiatives: Ongoing advancement of GLP‑1 related technologies aimed at differentiated health‑wellness solutions, focusing on scientific foundation, IP protection, and scalable commercialization potential.
• Financing Update: Completed an upsized financing that bolsters the balance sheet; specific terms (price per unit, gross proceeds, warrant details) were not disclosed in the release.
• Management Commentary: CEO Geoff Benic highlighted the NIRLAB device sale as a key operational milestone; Chairman Raf Souccar emphasized disciplined capital management and strategic positioning at the intersection of innovation, public safety, and wellness.

Notable Quotes

“The completion of our first NIRLAB device sale marks an important operational milestone for Safe Supply… we remain focused on disciplined execution as we advance our strategy across health, safety, and wellness.” – Geoff Benic, CEO

“Safe Supply is positioning itself at the intersection of innovation, public safety, and wellness. These are areas of increasing importance for governments, institutions, and communities alike.” – Raf Souccar, Chairman of the Board